CIBC Asset Management
CERE

CIBC Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

CIBC Asset Management’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-5,092
Closed -$208K – 1243
2024
Q2 		$208K Buy
+5,092
New +$212K ﹤0.01% 1009

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

CIBC Asset Management's CERE Position: Q3 2024 in Review

CIBC Asset Management sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 5,092 shares — an estimated $208K sold.

CIBC Asset Management first reported a position in CERE in Q2 2024 and held it in 1 quarter. The position peaked at $208K in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • CIBC Asset Management reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • CIBC Asset Management sold 5,092 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $208K.
  • CIBC Asset Management first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024 and held it in 1 quarter.
  • CIBC Asset Management's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $208K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on CIBC Asset Management's 13F filing for Q3 2024, filed 6 Nov 2024.